Deep Blue Medical Advances
- Industry
- Medical Devices
- Founded Year
- 2015
- Headquarters
- Durham, North Carolina
- Employee Count
- 0
Key People
- Bill Perry - CEO
- Dr. Howard Levinson - Founder and Chief Medical Officer
Assessment
- Team
-
Aspect: First-time physician innovator
Summary: The leadership team includes a physician innovator with significant medical expertise.
While the presence of a physician innovator brings valuable medical insight, the absence of experienced MedTech entrepreneurs may pose challenges in navigating the medical device market effectively.
- Clinical Need
-
Aspect: Very Strong
Summary: High recurrence rates in hernia repairs indicate a significant need for improved solutions.
The T-Line Hernia Mesh aims to reduce hernia recurrence rates, addressing a pressing clinical need and potentially improving patient outcomes significantly.
- Competition
-
Aspect: Very crowded + Strategics
Summary: The hernia repair device market is highly competitive with numerous established players.
Deep Blue Medical Advances faces competition from well-established companies with extensive resources and market presence, making market penetration challenging.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing a hernia mesh with superior anchor strength presents moderate technical challenges.
Creating a mesh that offers enhanced anchor strength without compromising biocompatibility involves overcoming material and design challenges.
- Patent
-
Aspect: Applied
Summary: The company has applied for patents for its T-Line Hernia Mesh.
If granted, these patents could provide a competitive edge by protecting the unique aspects of their product.
- Financing
-
Aspect: SBIR/SEED
Summary: Initial funding includes awards such as the Luis Villalobos Award.
Recognition and funding from reputable organizations provide financial support and validation of the company's innovation.
- Regulatory
-
Aspect: 510k/PMA
Summary: The T-Line Hernia Mesh has received FDA 510(k) clearance.
FDA clearance allows the company to market its product in the U.S., a significant milestone in the regulatory process.
Opportunity Rollup
- Odds of Success
- 4
- Peak Market Share
- 6.1
- Segment CAGR
- 4.4%
- Market Segment
- Hernia Repair Devices
- Market Sub Segment
- Hernia Mesh
Year Post Launch | Market Penetration (%) |
---|---|
1 | 0.30 |
2 | 0.91 |
3 | 2.13 |
4 | 4.27 |
5 | 6.10 |
Key Takeaway
Deep Blue Medical Advances addresses a significant clinical need with its innovative T-Line Hernia Mesh, but faces challenges in a competitive market dominated by established players.